| 51 |
26856709 | Impact of CYP3A5 and MDR-1 gene polymorphisms on the dose and level of tacrolimus among living-donor liver transplanted patients: single center experience. | 2016 |
3 |
| 52 |
27503662 | Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms. | 2016 Aug 9 |
2 |
| 53 |
28164520 | The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. | 2016 Oct 1 |
5 |
| 54 |
25590378 | The functional implications of common genetic variation in CYP3A5 and ABCB1 in human proximal tubule cells. | 2015 Mar 2 |
2 |
| 55 |
25673014 | The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients. | 2015 May |
4 |
| 56 |
25781547 | ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: a Next Generation Sequencing approach. | 2015 Sep 1 |
2 |
| 57 |
25817604 | ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis. | 2015 May 20 |
5 |
| 58 |
25916520 | Relationship between mRNA expression levels of CYP3A4, CYP3A5 and SXR in peripheral mononuclear blood cells and aging in young kidney transplant recipients under tacrolimus treatment. | 2015 |
1 |
| 59 |
26184414 | Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. | 2015 Sep |
1 |
| 60 |
26228923 | Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. | 2015 |
2 |
| 61 |
26307985 | Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. | 2015 Aug 25 |
1 |
| 62 |
26450467 | Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients. | 2015 Oct |
3 |
| 63 |
26543771 | CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients. | 2015 |
2 |
| 64 |
26622455 | Investigation of CYP 3A5 and ABCB1 gene polymorphisms in the long-term following renal transplantation: Effects on tacrolimus exposure and kidney function. | 2015 Sep |
1 |
| 65 |
26770526 | Relationships of related genetic polymorphisms and individualized medication of tacrolimus in patients with renal transplantation. | 2015 |
2 |
| 66 |
28356851 | Pharmacogenetics may Influence Tacrolimus Daily Dose, but not Urinary Tubular Damage Markers in the Long-Term Period after Renal Transplantation. | 2015 Oct |
1 |
| 67 |
24033383 | Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus. | 2014 Jan |
1 |
| 68 |
24528196 | Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. | 2014 Aug |
1 |
| 69 |
24621983 | ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines. | 2014 |
10 |
| 70 |
24656020 | Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients. | 2014 |
1 |
| 71 |
24658440 | P-glycoprotein and drug resistance in systemic autoimmune diseases. | 2014 Mar 20 |
2 |
| 72 |
24739669 | CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. | 2014 Dec |
1 |
| 73 |
25242754 | Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. | 2014 Sep |
4 |
| 74 |
25521359 | Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients. | 2014 Dec |
1 |
| 75 |
23107770 | Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. | 2013 Jan 10 |
7 |
| 76 |
23274970 | Interpreting tacrolimus concentrations during pregnancy and postpartum. | 2013 Apr 15 |
1 |
| 77 |
23364483 | CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). | 2013 Mar 27 |
1 |
| 78 |
23574377 | Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms. | 2013 Aug |
2 |
| 79 |
23617933 | Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients. | 2013 Apr 23 |
1 |
| 80 |
23622581 | Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. | 2013 Apr |
3 |
| 81 |
23633119 | Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. | 2013 Sep |
4 |
| 82 |
23743668 | Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. | 2013 Aug |
7 |
| 83 |
23900887 | Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. | 2013 Nov |
1 |
| 84 |
23990505 | A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation. | 2013 Oct |
1 |
| 85 |
24042126 | The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis. | 2013 Dec 1 |
5 |
| 86 |
24059111 | [Association of CYP3A5 and MDR1 genetic polymorphisms with the blood concentration of tacrolimus in Chinese liver and renal transplant recipients]. | 2013 Jul |
2 |
| 87 |
24120259 | Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. | 2013 Nov |
4 |
| 88 |
24231473 | The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients. | 2013 Nov |
1 |
| 89 |
24687344 | MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. | 2013 Sep-Oct |
1 |
| 90 |
27121561 | Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Transplant Patients. | 2013 Jan |
2 |
| 91 |
22008665 | The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients. | 2012 Jan 10 |
2 |
| 92 |
22101623 | The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation. | 2012 May |
1 |
| 93 |
22183771 | Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients. | 2012 May |
1 |
| 94 |
22309416 | Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population. | 2012 Feb |
2 |
| 95 |
22310591 | Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients. | 2012 Jan |
6 |
| 96 |
22504573 | Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients. | 2012 Aug |
3 |
| 97 |
22743729 | Tacrolimus-induced nephrotoxicity and genetic variability: a review. | 2012 Apr-Jun |
4 |
| 98 |
23146479 | Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation. | 2012 Nov |
1 |
| 99 |
20571034 | Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period? | 2011 Apr |
3 |
| 100 |
20629603 | Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant. | 2011 Jan |
6 |